Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
16 lessons
8m5-Amino-1MQ dosage searches grew more than 1,400 percent. The stack page already ranks. This companion stays on milligram ranges and oral versus subQ handling language.
9mSearchers asking KLOW peptide dosage or how often to take KLOW usually want a pin calendar. The blend has no trial of its own. The numbers people repeat are component folklore plus listing math.
8mNAD+ 1000 mg reconstitution searches want a 1 g calculator. The existing NAD+ guide covers smaller vials. This page does the 1000 mg arithmetic and keeps it educational.
9mAmycretin is Novo's dual GLP-1 + amylin molecule with both oral and injectable programs. Here's the early dosing map and why Phase 3 is the next SEO wave.
8mCagrilintide is the amylin half of CagriSema. Here's the dosing map people actually search — 2.4 mg weekly combo context, monotherapy signal, and how not to cross-titrate with eloralintide.
8mCT-388 is Roche's weekly tirzepatide-class dual agonist with Phase 2 doses up to 24 mg. Here's the dosing vocabulary and the weight-loss signal searchers want.
8mSearching for eloralintide dosage? Here is the clean map of Phase 2 once-weekly doses, titration arms, and weight-loss results — framed as clinical education, not a DIY protocol.
9mMariTide is the once-monthly obesity candidate people keep comparing to weekly GLP-1s. Here's the Phase 2 dosing map — 140 / 280 / 420 mg and the escalation arms that mattered for tolerability.
7mMazdutide is a once-weekly glucagon/GLP-1 dual agonist with clear Phase 3 dose anchors at 4 mg and 6 mg. Here's the dosing and results map searchers want.
8mOrforglipron is Lilly's once-daily oral small-molecule GLP-1. Here's the titration ladder searchers want — 1 mg start, step-ups every four weeks, and Phase 3 maintenance doses.
8mPetrelintide is the Roche/Zealand once-weekly amylin analog drawing GLP-1-level attention for tolerability. Here's the Phase 2 dosing pattern, results, and what to track.
8mSS-31 dosage searches keep climbing alongside MOTS-c. Here's the practical elamipretide dosing map — daily mg ranges, timing, cycling, and what to track for mitochondrial protocols.
8mSurvodutide is Boehringer's glucagon/GLP-1 dual agonist. Here's the dosing map from dose-finding through Phase 3 — weekly mg ranges, escalation logic, and what the weight-loss data showed.
5mLearn the proper technique for reconstituting NAD+ vials, understanding concentration calculations, and building an effective dosing protocol for your research needs.
10mThe complete guide to safely reconstituting peptides, including dosage calculations and best practices.
12mExplore the healing peptide BPC-157, nicknamed the 'Wolverine peptide' for its remarkable regenerative properties.
Also available at /blog for legacy links.